Key Dates
6 May 2008
Notification of Acceptances
26 May 2008
Early Registration Cut-off Date
9 June 2008
Late breaking Abstract Submission Date
2 July 2008
Pre & Post Congress Tours
2 July 2008
Accommodation Bookings
2 July 2008
Social Program Bookings
2 July 2008
Congress Day Tours
9-10 August 2008
Postgraduate Weekend Courses
10-14 August 2008
Congress Opens
Prof Maria Grazia Roncarolo
Maria Grazia Roncarolo is the Director of the San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET) in Milan, Italy since June 2000, and Professor in Pediatrics, School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy, since November 2001.
She is a M.D., specialized in Pediatrics and Immunology. Since July 2003, she is Chief of Clinic, Pediatric Immunology and Hematology and Clinical Research Unit (CRU-P), San Raffaele Hospital and San Raffaele Scientific Institute.
She worked in Lyon for several years at the Edouard Herriot Hospital and at the Laboratory for Immunological Research UNICET on the mechanism of tolerance in severe combined immunodeficiency (SCID) patients transplanted with allogenic hematopoietic stem cells.
She worked for more than 8 years at the DNAX Research Institute of Molecular and Cellular Biology, Human Immunology Department, in Palo Alto, CA, on the basic biology of hematopoietic stem cells, cytokines, and transplantation tolerance. She has a long-lasting interest in the mechanisms, which induce and maintain tolerance in bone marrow transplantation, organ transplantation, autoimmune disease and gene therapy.
In addition, she is interested in investigating the mechanisms underlying the immune defects, and identifying new cures for children with severe combined immunodeficiency (SCID) and other forms of primary immunodeficiencies.
Hugh Auchincloss Jr
Hugh Auchincloss, Jr., M.D., is Principal Deputy Director of the National Institute of Allergy and Infectious Diseases at the United States National Institutes of Health. Prior to his appointment at NIAID, Dr. Auchincloss was a transplant surgeon and Professor of Surgery at Harvard Medical School.
For more than 17 years, he operated a laboratory in transplantation immunology at Massachusetts General Hospital in Boston with multiple research interests, including the mechanisms and control of tissue graft rejection, the mechanisms of transplantation tolerance induction, the use of pancreas and islet transplantation for the treatment of diabetes, and the prevention of recurrent autoimmunity.
In 1998, he founded the Juvenile Diabetes Research Foundation Center for Islet Transplantation and served as its director until 2003. He subsequently served as Chief Operating Officer of NIAID's Immune Tolerance Network. Dr. Auchincloss serves as the chairman of the Food and Drug Administration (FDA) Subcommittee on Xenotransplantation and in 2005 was elected President of the American Society of Transplantation. He received his medical degree from Harvard Medical School in 1976.
Return to the Plenary Program









